Skip to content

Clinical trials

Phase 4 Melanoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 4 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20081
20121
20132
20141
20151
20181
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Terminated2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clinigen, Inc.2
Novartis Pharmaceuticals2
Dartmouth-Hitchcock Medical Center1
Mayo Clinic1
National Institute of Neurological Disorders and Stroke (NINDS)1
OHSU Knight Cancer Institute1
RECORDATI GROUP1
University of Alabama at Birmingham1
Vanderbilt University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma11
Neoplasm Metastasis4
Lung Neoplasms3
Brain Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Skin Neoplasms2
Acromegaly1
Basal Cell Carcinoma1
Breast Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.